drugset / Trial / NCT03034018

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

NCT03034018

Phase 4 Completed 60 enrolled Brigham and Women's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to determine the effect of suvorexant on insomnia symptoms in peri- and postmenopausal women who are experiencing sleep difficulties related to nighttime hot flashes.

Timeline

Start
2017-05-25
Primary completion
2020-04-03
Completion
2020-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Suvorexant Small molecule 10 mg Oral
Subject Suvorexant Small molecule 20 mg Oral

Indications